Americans spend more time traveling and waiting for health appointments than for any other service, according to a new analysis. » Read More
By: Lori Ioannou
An Israeli start-up called Healthy.io has developed an FDA-cleared at-home smartphone urinalysis test to help people test their kidneys for proteins, a sign of damage to the organ. Thirty million Americans have chronic kidney disease. » Read More |
By: Christina Farr
Penn Medicine shows that patients search for health-related terms three times more than normal a week before an emergency room visit. » Read More |
By: David Reid
Cannabis stocks are the next huge growth area and wont collapse like cryptocurrencies says one wealth adviser. » Read More |
A diet full of whole grains can decrease the risk of liver cancer by nearly 40 percent, according to a new study released Thursday.
In interviews with Axios and CNN, U.S. Food and Drug Administration Commissioner Scott Gottlieb said the federal government could intervene in states' vaccine exemptions.
The joint health-care venture between Amazon, J.P. Morgan and Berkshire Hathaway is primarily focused on simplifying health insurance, according to newly released court testimony from Chief Operating Officer Jack Stoddard.
Amazon's senior health leader, Taha Kass-Hout, talks up the company's advances in artificial intelligence.
The anecdote reported by Vanity Fair sheds light on the chaos that consumed Theranoss final stretch.
Johnson & Johnson has received subpoenas from the Justice Department and the SEC related to litigation involving alleged asbestos contamination in its Baby Powder line.
Pinterest has taken the boldest step thus far among the largest tech giants in blocking bad health advice.
CVS gave its 2019 earnings forecast, which fell well short of expectations, disappointing investors and stoking fears about CVS' core business.
Bristol-Myers Squibb confirms Starboard's stake in the company and says the $74 billion deal to acquire cancer drugmaker Celgene is "on track" to close during the third quarter.
U.S. healthcare plan and pharmacy benefits manager Magellan Health will explore selling itself after coming under pressure to do so from activist hedge fund Starboard Value LP, people familiar with the matter said on Wednesday.
A company that charged patients thousands of dollars for infusions of blood plasma from younger donors said Tuesday that it had stopped treating patients after the Food and Drug Administration warned consumers against such treatments, purported to prevent aging and memory loss, NBC News reports.
CVS Health shares crater after the company disappointed investors with a lower-than-expected earnings forecast for the year as it integrates Aetna.
The FDA is advising against "young blood" infusions, in which people are infused with plasma from young donors. It warns consumers that clinics are making unproven claims that the treatment can reverse aging.
Medical device maker Medtronic on Tuesday beat Wall Street estimates for quarterly profit, driven by higher sales in its surgical products unit and restorative therapies group.
As people shop online more, CVS and Walgreens are trying to give people reasons to keep coming into their stores.
A foldable drone has been developed by researchers at the University of Zurich to assist with search and rescue missions.
Get the best of CNBC in your inbox
Data also provided by 
